Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
9.56
-0.92 (-8.78%)
At close: Dec 5, 2025, 4:00 PM EST
9.68
+0.12 (1.26%)
After-hours: Dec 5, 2025, 7:44 PM EST
Personalis Employees
As of December 31, 2024, Personalis had 229 total employees, including 228 full-time and 1 part-time employees. The number of employees increased by 4 or 1.78% compared to the previous year.
Employees
229
Change (1Y)
4
Growth (1Y)
1.78%
Revenue / Employee
$301,760
Profits / Employee
-$322,633
Market Cap
848.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PSNL News
- 17 days ago - Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 25 days ago - Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer - Business Wire
- 4 weeks ago - Personalis, Inc. (PSNL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Personalis Reports Third Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Personalis to Announce Third Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing - Business Wire
- 2 months ago - Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test - Business Wire